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All included studies were prospective cohort studies on women with threatened miscarriage. Of 139 the 15 studies, all excepting four (Hanita et al., 2012 , Jouppila et al., 1980 Ruge et al., 1990 ; 140 Westergaard et al., 1985) included women of gestational age less than 14 weeks. The 141 characteristics of the included studies are summarized in Table 1 and excluded studies in Table  142 2. 143
Risk of bias assessment 144
The risk of bias was assessed in 4 main domains using the 'QUADAS-2: A Revised Tool' for 145 patient selection, index test, reference standard and flow and timing (Figure 2 ). Few of the 146 studies reviewed did not specify their exclusion criteria and therefore scored 'high risk' for 147 patient selection. For the index test most studies had not specified a cut off level to differentiate 148 between ongoing pregnancies and miscarriage, and those that had specified a cut off level had 149 not specified it prior to starting the project. This is an area of major bias for the included 150 studies. The reference standard for the review is occurrence of miscarriage which can be best 151 diagnosed using USS or clinical history followed by histopathological examination of the 152 products of conception. Some studies used telephone interviews or review of case notes to 153 determine the outcome, which can contribute to bias. It was not clearly stated in the studies 154 whether the reference standard was interpreted without the knowledge of the index test. 155
However, this is unlikely to affect applicability of the studies since miscarriage is an objective 156 diagnosis and is not prone to subjective interpretation. In the flow and timing section of the 157 QUADAS-2 tool, although it was difficult to predict a specific time interval from the index test to 158 reference standard (occurrence of miscarriage), we used the sampling question to see whether 159 the patients were followed up until at least 23 weeks, so as not to miss any miscarriages (World 160
Health Organization (WHO, 2001) has defined miscarriage as premature loss of a fetus up to 23 161 weeks of pregnancy and weighing up to 500 g). Therefore, quality concerns exist for the 162 diagnostic accuracy studies included for the prediction of the miscarriage. 163 were summarized for the biomarkers serum hCG, progesterone, estradiol, PAPP-A and CA  165   125. Test results were tabulated in a 2 x 2 table and forest plots constructed for the sensitivity  166 and specificity of the biomarker with their confidence intervals. There were other serum 167 biomarkers for which only single studies were available and therefore meta-analysis could not 168 be performed. These were HPL, AFP, Schwangerschafts Protein 1 (SP1) and Pregnancy Zone 169 Protein (PZP) (Westergaard et al., 1985) ; Plasma Renin Activity (PRA), Plasma Renin Substrate 170 (PRS) and Sex-Hormone Binding Globulin (SHBG) (Siimes et al., 1983) Scarpellini et al., 1975) . The forest plots were plotted separately for studies that used β 180 hCG and intact hCG (Figure 3a and 3b) . Further analysis using HSROC (β hCG and intact hCG) 181 showed a sensitivity of 44% (95% CI 17-75%), a specificity of 86% (95% CI 80-91%), a positive 182 likelihood ratio of 3.37(95% CI 1.98-5.74%) and a negative likelihood ratio of 0.63(95% CI 0.36-183 1.11) (Table 3 and Figure 3c ). 184
Quantitative data summary and synthesis of results

Data
Serum Progesterone 185
Six studies with 481 women used serum progesterone to predict outcome in threatened However, it is proven that the measurement of free β hCG subunits offer no clinical advantage 260 over measurement of intact hCG during the first half of pregnancy (Thomas et al., 1990) . In this 261 meta-analysis, therefore, studies on βhCG and intact hCG were combined to create a single SROC 262 curve (Figure 3c) . 263 Lin and Liu (1995) found that the sensitivity of estradiol and hCG in predicting pregnancy 264 outcome at week eight of gestation was better than that of serum progesterone (80 and 85%, 265 Westergaard et al, (1983) were the first to evaluate PAPP-A in the prediction of pregnancy 285 outcome in women presenting with a threatened miscarriage. They concluded that PAPP-A 286 measurement might be useful in differentiating pregnancies that will have normal outcome 287 from those which will not (Westergaard et al., 1983) . The abnormal levels were frequently 288 observed weeks before the clinical progression of spontaneous miscarriage while the fetus was 289 still alive (Westergaard et al., 1983) . Ruge et al. (1990) observed that serum levels of PAPP-A 290 were significantly lower in women with vaginal bleeding in early pregnancy than normal 291 HRU_15_0045 15 pregnant women, however, they failed to differentiate between those who either later 292 miscarried or continued with their pregnancy. PAPP-A as a biochemical marker for the 293 prediction of early pregnancy outcome has certain limitations, which include (1) inability to 294 differentiate between normal and abnormal pregnancies at very early gestation (< 6-7 weeks) 295 (Ruge et al., 1990; Yovich et al., 1986) and (2) (Table II) . 314
We used demonstrable fetal heartbeat on USS as a strict inclusion criterion for the studies 315 because prediction of miscarriage will benefit this population the most. Similarly, PUL 316 population was excluded, as undiagnosed ectopic pregnancies could skew the outcomes. 317
There are a few limitations for this meta-analysis. Most of the included studies had not specified 318 a cut off value for the specific biochemical marker in the prediction of the outcome of 319 miscarriage. Because of this drawback, we could only comment on the utility of each 320 biochemical marker in predicting miscarriage and could not determine a useful 'cut off level'. 321
Also it is known that the levels of serum progesterone, hCG, CA 125, estradiol and serum PAPP-322
A change with each week of gestation. Most of the included studies did not take this into 323 consideration. Ideally, the levels of these biochemical markers should be compared against 324 gestation specific normal values. 325
Another drawback is the quality and reporting of the included studies. analysis (Azogui et al., 1996 , Johns et al., 2007 Vavilis et al., 2001) . 333
In conclusion, biochemical markers can be used to predict the outcome of threatened 334 miscarriage particularly serum CA125. Recently, high-sensitivity C-reactive protein (HSCRP) has 335 been studied in threatened miscarriage (Jauniaux et al. 2015) and its role along with CA 125 336 needs to be further investigated in larger studies. In order to reliably interpret the biochemical 337 markers in early pregnancy, gestational age specific normograms are required and pre specified 338 cut-off values would be important for the study design. Ultrasound markers may have a role in 339 accurately predicting outcome of threatened miscarriage either alone or in combination with 340 the biochemical markers. Moreover, oxidative stress markers in maternal serum or urine may 341 have potential role in predicting miscarriage, but this needs further research. Overall, it is 342 important to consider biomarkers that can reliably predict an ongoing pregnancy rather thanpredicting miscarriage since this would allay patient anxiety and be cost-effective. Future, large 344 well-designed prospective cohort studies are needed with rigorous quality control and 345 reporting methodology to accurately predict miscarriage outcome. 
